ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,379.40
-1.79%
S&P ASX All Technology
3,901.70
-2.06%
Brent Oil
76.49
0.18%
US Dollar vs AUD
1.62713
-0.02%
Bitcoin
95,078.44
-2.68%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Evofem Biosciences Inc (EVFM) Share Price

Evofem Biosciences Inc

Evofem Biosciences Inc (EVFM)

Evofem Biosciences Inc (QB)
0.4782
0.00
(0.00%)
Closed 03 February 8:00AM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.4782
Bid
0.465
Offer
0.468
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
2.716M
Previous Close
0.4782
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,680,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
8.8
Revenue
18.22M
Net Profit
50M

About Evofem Biosciences Inc

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmi... Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.evofem.com
Headquarters
Wilmington, Delaware, USA
Founded
-

Ask ADVFN Intelligence (AI)

EVFM Latest News

More News

Biopharma Partners with Telemed Firm and Shares are Climbing

This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership To...

28 June 2024
AllPennyStocks.com

Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire SAN DIEGO, June 1, 2023 Increased net product revenue more than 35% in the first quarter of 2023...

01 June 2023
PR Newswire (US)

Evofem Biosciences Announces 1-for-125 Reverse Stock Split

Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire SAN DIEGO, May 17, 2023 -- CUSIP number for Evofem will change to 30048L302 on May 18, 2023 -- -- Ticker symbol will change...

18 May 2023
PR Newswire (US)

Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required PR Newswire SAN DIEGO, April 12, 2023 — Improves Phexxi coverage for more than 5.8 million New York...

12 April 2023
PR Newswire (US)

Evofem Biosciences Announces Cost Reduction Measures

Evofem Biosciences Announces Cost Reduction Measures PR Newswire SAN DIEGO, March 21, 2023 – Company cuts management pay and lowers headcount to decrease operating costs – – Reductions align with...

21 March 2023
PR Newswire (US)

Evofem Biosciences Appoints Interim Chief Financial Officer

Evofem Biosciences Appoints Interim Chief Financial Officer PR Newswire SAN DIEGO, March 9, 2023 SAN DIEGO, March 9, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to...

09 March 2023
PR Newswire (US)

Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering

Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering PR Newswire SAN DIEGO, Feb. 28, 2023 -- Phexxi is the first and only hormone-free contraceptive offered by reproductive...

01 March 2023
PR Newswire (US)

Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi PR Newswire SAN DIEGO, Feb. 27, 2023 -- Evofem now has four Orange Book listed patents covering...

27 February 2023
PR Newswire (US)

Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value

Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value PR Newswire SAN DIEGO, Feb. 23, 2023 SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB:...

24 February 2023
PR Newswire (US)

Costco Adds Phexxi® to Member Prescription Program

Costco Adds Phexxi® to Member Prescription Program PR Newswire SAN DIEGO, Jan. 10, 2023 SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that...

11 January 2023
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

EVFM - Frequently Asked Questions (FAQ)

What is the current Evofem Biosciences share price?
The current share price of Evofem Biosciences is US$ 0.4782
How many Evofem Biosciences shares are in issue?
Evofem Biosciences has 5,680,000 shares in issue
What is the market cap of Evofem Biosciences?
The market capitalisation of Evofem Biosciences is USD 2.72M
What is the 1 year trading range for Evofem Biosciences share price?
Evofem Biosciences has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the cash to sales ratio of Evofem Biosciences?
The cash to sales ratio of Evofem Biosciences is 0
What is the reporting currency for Evofem Biosciences?
Evofem Biosciences reports financial results in USD
What is the latest annual turnover for Evofem Biosciences?
The latest annual turnover of Evofem Biosciences is USD 18.22M
What is the latest annual profit for Evofem Biosciences?
The latest annual profit of Evofem Biosciences is USD 50M
What is the registered address of Evofem Biosciences?
The registered address for Evofem Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Evofem Biosciences website address?
The website address for Evofem Biosciences is www.evofem.com
Which industry sector does Evofem Biosciences operate in?
Evofem Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 16.92
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.4033
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.88
(0.00%)
0
AACGATA Creativity Global
US$ 0.79325
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 16.92
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.4033
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.88
(0.00%)
0
AACGATA Creativity Global
US$ 0.79325
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 16.92
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.4033
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.88
(0.00%)
0
AACGATA Creativity Global
US$ 0.79325
(0.00%)
0

Discussion

View Full Feed
jeunke22 jeunke22 8 minutes ago
Good news:
1. You are still here asking questions.
2. Scaling is not an issue.
3. Lightwave seems to have accommodated the Tier 1’s. The process completion of the PIC or chiplet is in the Tier 1 lap (is what they prefer).
4. Lightwave is able to deal with less integra
LWLG
gdl gdl 10 minutes ago
https://www.msn.com/en-us/news/politics/tell-them-how-proud-you-are-adam-schiff-unleashes-on-kash-patel-during-confirmation-hearing/vi-AA1yiWys#

The New FBI Director will put a US SENATOR in Jail once he is elected. Poor Adam Schiff. I applauded his brutal attack but afraid it will
barnstormer barnstormer 14 minutes ago
ATL, I wasn't confused, was just trying to clarify the language re Huawei in the 2022 10-K which I assumed was limited to ownership of acreage and buildings. Always assumed the Facility processes and equipment was separate from them.
NWBO
TitaniumOracle58 TitaniumOracle58 18 minutes ago
https://support.withings.com/hc/en-us/community/posts/32339339158161-How-Do-I-Official-Contact-Kraken-Support-Number
9Coastal 9Coastal 18 minutes ago
Ditto. I appreciated your "expressed opinion". As odd as it sounds, and I have had my reservations after digging all I could about Emil (for one).. I can't put my finger on it.. BUT, this stock (could).. shock us all. No matter. Time will tell. Unless .. VPLM TRULY drags it on endlessly. Nothing is
VPLM
LVerstee LVerstee 20 minutes ago
For the people who missed it.

@RealDutch fired this remark

He is in Hyderabad now.

Contradicting Laxmi's email

(9) 1st Late Night (2nd Early Hours) -- Flying back to Hong Kong.

(10) 3rd - 7th -- Hong Kong -- banking set u
ITUP
TitaniumOracle58 TitaniumOracle58 20 minutes ago
https://myagileplm.com/question/how-do-i-official-contact-kraken-support-number/
COOP
TitaniumOracle58 TitaniumOracle58 20 minutes ago
https://meritforcustomers.microsoftcrmportals.com/forums/general-discussion/2cd5448b-f8e1-ef11-b541-7c1e52aafdd2
COOP
TitaniumOracle58 TitaniumOracle58 22 minutes ago
https://support.withings.com/hc/en-us/community/posts/32339339158161-How-Do-I-Official-Contact-Kraken-Support-Number
COOP
TitaniumOracle58 TitaniumOracle58 22 minutes ago
https://support.withings.com/hc/en-us/community/posts/32339339158161-How-Do-I-Official-Contact-Kraken-Support-Number
Researchfyi Researchfyi 24 minutes ago
Someone asked LL about contracts and if he had to choose between two companies, which one would he favor.

I couldn’t hear the answer because as LL was replying he took a big bite out of a nice ripe red pomegranate, a.k.a Chinese Apple 🍎. :)

and then I thought I
LQMT
Tahoe2468 Tahoe2468 25 minutes ago

Well hopefully this won't effect us uhhhhhh
KRTL
lakers17 lakers17 29 minutes ago
Crypto BTC now $95,000 and was $91,000. Going to be an ugly stock day today too.
ATLnsider ATLnsider 29 minutes ago
barnstormer, it’s always good to see your posts too.

I think the confusion for some is, confusing who owns the building and land versus who owns the Sawston Facility. It’s hard for some to separate in their minds, and to distinguish who owns the building and the land, versus who owns
CDMO
9Coastal 9Coastal 35 minutes ago
A worthy point you make "Their intentions became plenty obvious when they committed the biggest reneg ever seen on their previous promises re: their intentions what to do with patents.". Nevertheless, this has been and will continue to be an interesting watch..
VPLM
Peeteman Peeteman 36 minutes ago
You’re right. However, you also have 600 million shares currently restricted. When do they become unrestricted. Also, 415 million more authorized shares that can become outstanding. Still total common share amount is a drop in the hat compared to other otc companies out there with no income and 10 b
AXXA
SkeBallLarry SkeBallLarry 37 minutes ago
Panama has agreed to allow U.S. Navy ships free passage through the Panama Canal after Secretary of State Marco Rubio’s visit. It will also terminate its Panama Canal deal with China and exit China’s 2017 "Belt and Road Initiative."

https://x.com/JDunlap1974/status/1886294598747627585
SkeBallLarry SkeBallLarry 37 minutes ago
Panama has agreed to allow U.S. Navy ships free passage through the Panama Canal after Secretary of State Marco Rubio’s visit. It will also terminate its Panama Canal deal with China and exit China’s 2017 "Belt and Road Initiative."

https://x.com/JDunlap1974/status/1886294598747627585
SkeBallLarry SkeBallLarry 38 minutes ago
Panama has agreed to allow U.S. Navy ships free passage through the Panama Canal after Secretary of State Marco Rubio’s visit. It will also terminate its Panama Canal deal with China and exit China’s 2017 "Belt and Road Initiative."

https://x.com/JDunlap1974/status/1886294598747627585
jog49 jog49 39 minutes ago
"So now we wait for the Senate to confirm Bill."

Some here qualify as world class "waiters", and not the kind in restaurants!
FNMA
Tahoe2468 Tahoe2468 40 minutes ago
Any idea how much Sigma Corp in Bolivia is worth or sales a year ? Just curious how big they are... ??? 
KRTL
1hunglo 1hunglo 41 minutes ago
The Senate will vote on RFK jr’s confirmation Tuesday, I hope he is approved. He’s the best man for the job imo.
RDGL
wimike wimike 43 minutes ago
Baxers Thank you so much for your story and well wishes. She is 72 and they told her she will be sore for many months. She still works full-time (from home) and sat out the first 6 weeks.
She did go through rehab. They also gave her exercises to follow and sent home a unit for exercising he
NWBO
9Coastal 9Coastal 43 minutes ago
Interesting point. Appreciate.
VPLM
Peeteman Peeteman 46 minutes ago
All we know as shareholders is what the company tells us. Stock repurchase program put in place; no stock buybacks by company as of last financial statement; and debts being repaid which probably include derivative financing and may or may not have clauses in them that don’t allow company to repurch
AXXA

Your Recent History

NASDAQ
EVFM
Evofem Biosciences
BIT
P1INH2
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads